The Criminal Justice Coordinating Center of Excellence (CJ CCoE) at Northeast Ohio Medical University and the Office of Ohio Attorney General Dave Yost are co-sponsoring a webinar to describe the benefits and indications for the use of long-acting injectable antipsychotic medications compared with oral antipsychotic medications. The webinar will also address the unique benefits and use of Clozaril (clozapine).
The webinar will be held from noon-1:15 p.m. Friday, March 12.
Erica Holbrook, M.D., in her fourth and final year of a general psychiatry residency at The Ohio State University Wexner Medical Center in Columbus, Ohio. Dr. Holbrook is a Chair of the Residents’ Advisory Council, a medical center-wide leadership group for all residents and fellows at OSU.
Erik Messamore, M.D., Ph.D., an associate professor in the Department of Psychiatry at Northeast Ohio Medical University and the Medical Director for the Best Practices in Schizophrenia Treatment (BeST) Center in NEOMED’s Department of Psychiatry.
Douglas Smith, M.D., the medical director/chief clinical officer, County of Summit Alcohol, Drug Addiction and Mental Health Services Board; a NEOMED associate professor of psychiatry; and director of community psychiatry for the NEOMED/Summa Health Psychiatry Residency Program.
Registration is required. Register here.
The webinar has been approved for one Continuing Medical Education credit.
For other questions, contact Ashley Eads at email@example.com or 330.325.6397.